Correlates of insomnia in patients with social phobia: Role of depression and anxiety

2011 ◽  
Vol 26 (S2) ◽  
pp. 171-171
Author(s):  
T. Raffray ◽  
A. Pelissolo
Keyword(s):  
Social Anxiety ◽  
Social Phobia ◽  
Sleep Disturbances ◽  
Depression Scale ◽  
Small Samples ◽  
Anxiety And Depression ◽  
Treatment Seeking ◽  
Bivariate Analysis ◽  
Post Traumatic Stress ◽  
Insomnia Severity

IntroductionMost of the literature examining sleep in anxiety disorders has focused on post-traumatic stress disorder and generalized anxiety disorder. Few studies have examined sleep disturbances in social phobia. Yet, social phobia has a lifetime prevalence of 12%. Previous studies assessed sleep disturbances in small samples of individuals with social phobia. Most studies reported bivariate analysis, the only multivariate analysis being in non treatment-seeking individuals.ObjectivesTo assess insomnia severity in a population of treatment-seeking patients with social phobia and investigate correlations between insomnia, depression, general anxiety, and social anxiety.AimsTo demonstrate that positive associations exist between anxiety, depression, and insomnia in patients with social phobia, depression contributing the most to insomnia severity.MethodsOne hundred and seventy-nine treatment-seeking individuals with a DSM-IV diagnosis of social phobia completed the Insomnia Severity Index (ISI), the Hospital Anxiety and Depression Scale (HAD-A and HAD-D) and the Liebowitz Social Anxiety Scale (LSAS).ResultsTwo-thirds of our sample had insomnia. Depression, anxiety, social anxiety, and insomnia were positively correlated. Sex, HAD-A and LSAS significantly contributed in explaining the ISI total score after accounting for age, medication use, and depression, whereas HAD-D was not a significant contributor. The model explained 33.5% of the overall variance.ConclusionAssessing sleep quality and quantity, and understanding the interactions between insomnia, anxiety and depression, is needed to improve treatment in patients with social phobia and could allow adapting cognitive and behavioral therapy for insomnia programs to social anxiety.

scholarly journals Sleep patterns and symptoms of anxiety and depression in patients with chronic pain

2009 ◽  
Vol 67 (1) ◽  
pp. 25-28 ◽  
Author(s):  
Martha M.C. Castro ◽  
Carla Daltro
Keyword(s):  
Chronic Pain ◽  
Sleep Disturbances ◽  
Myofascial Pain ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Sleep Patterns ◽  
Symptoms Of Depression ◽  
High Prevalence ◽  
The Mean

BACKGROUND: Sleep disturbances and symptoms of anxiety and depression have been shown to be involved in the genesis and perpetuation of chronic pain. OBJECTIVE: To evaluate sleep patterns and the prevalence of symptoms of anxiety and depression in patients with chronic pain. METHOD: Four hundred consecutive patients referred to a chronic pain outpatient clinic were investigated using patient charts, the numerical Visual Analogue Scale for the evaluation of pain, the Hospital Anxiety and Depression scale and the Mini-Sleep Questionnaire. RESULTS: The mean age of patients was 45.6±11.4 years. The most frequent medical diagnosis was myofascial pain followed by neuropathic pain. The prevalence of symptoms of anxiety was 72.8%, depression 93% and altered sleep patterns 93%. CONCLUSION: This study revealed a high prevalence of symptoms of depression and anxiety and alterations in sleep patterns in patients with chronic pain, justifying investigation into these disturbances in this group of patients.

scholarly journals Social anxiety in a multiple sclerosis clinic population

2009 ◽  
Vol 15 (3) ◽  
pp. 393-398 ◽  
Author(s):  
K Poder ◽  
K Ghatavi ◽  
JD Fisk ◽  
TL Campbell ◽  
S Kisely ◽  
...  
Keyword(s):  
Social Anxiety ◽  
Depression Scale ◽  
Research Unit ◽  
Anxiety Symptoms ◽  
Self Report ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Neurological Disability ◽  
General Anxiety ◽  
Neurologic Disability

Background Little is known about social anxiety in MS. Objective We estimated the prevalence of social anxiety symptoms and their association with demographic and clinical features in a clinic-attending sample of patients with MS. Methods Patients attending the Dalhousie MS Research Unit for regularly scheduled visits completed the Social Phobia Inventory (SPIN), the Hospital Anxiety and Depression Scale (HADS), and the Health Utilities Index (HUI). Neurological disability was determined by ratings on the Expanded Disability Status Scale (EDSS). Results A total of 251 patients completed self-report scales of anxiety and depression symptoms. In all, 245 (98%) provided sufficient data for analysis. In all, 30.6% ( n = 75) had clinically significant social anxiety symptoms as defined by a SPIN threshold score of 19. Half of those with social anxiety had general anxiety (HADSA ≥ 11) and a quarter had depression (HADSD ≥ 11). Severity of social anxiety symptoms was associated with reduced health-related quality of life and not related to neurological disability. Conclusions Social anxiety symptoms are common in persons with MS, contribute to overall morbidity, but are unrelated to the overall severity of neurologic disability. Greater awareness and routine systematic inquiry of social anxiety symptoms is an important component of comprehensive care for persons with MS.

scholarly journals Interpreting softmax predictions of sleep stage classification models

2021 ◽  
Author(s):  
Iris Huijben ◽  
Lieke WA Hermans ◽  
Allessandro C Rossi ◽  
Sebastiaan Overeem ◽  
Merel M van Gilst ◽  
...  
Keyword(s):  
Sleep Stage ◽  
Depression Scale ◽  
Severity Index ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Exclusion Criteria ◽  
Stage Classification ◽  
Sleep Stage Classification ◽  
Somatic Disorders ◽  
Insomnia Severity

<div>We used a dataset of nocturnal PSG recordings, collected as part of the Healthbed study, which main aim was development of technologies for sleep analyses. The dataset includes one clinical video-PSG recording for each subject, made according to the AASM recommendations in Sleep Medicine Center Kempenhaeghe Heeze, the Netherlands. The study included 96 (60 females) healthy subjects, with an age between 18 and 64. The exclusion criteria were: 1) any diagnosed sleep disorder, 2) a Pittsburgh Sleep Quality Index >= 6, or Insomnia Severity Index > 7, 3) indication of depression or anxiety disorder measured with the Hospital Anxiety and Depression Scale (score > 8), 4) pregnancy, shift work, use of any medication except for birth control medicine, and 5) presence of clinically relevant neurological or psychiatric disorders or other somatic disorders that could influence sleep.</div>

scholarly journals Interpreting softmax predictions of sleep stage classification models

2021 ◽  
Author(s):  
Iris Huijben ◽  
Lieke WA Hermans ◽  
Allessandro C Rossi ◽  
Sebastiaan Overeem ◽  
Merel M van Gilst ◽  
...  
Keyword(s):  
Sleep Stage ◽  
Depression Scale ◽  
Severity Index ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Exclusion Criteria ◽  
Stage Classification ◽  
Sleep Stage Classification ◽  
Somatic Disorders ◽  
Insomnia Severity

<div>We used a dataset of nocturnal PSG recordings, collected as part of the Healthbed study, which main aim was development of technologies for sleep analyses. The dataset includes one clinical video-PSG recording for each subject, made according to the AASM recommendations in Sleep Medicine Center Kempenhaeghe Heeze, the Netherlands. The study included 96 (60 females) healthy subjects, with an age between 18 and 64. The exclusion criteria were: 1) any diagnosed sleep disorder, 2) a Pittsburgh Sleep Quality Index >= 6, or Insomnia Severity Index > 7, 3) indication of depression or anxiety disorder measured with the Hospital Anxiety and Depression Scale (score > 8), 4) pregnancy, shift work, use of any medication except for birth control medicine, and 5) presence of clinically relevant neurological or psychiatric disorders or other somatic disorders that could influence sleep.</div>

THE STRUCTURE OF SOMATIC PATHOLOGY IN PATIENTS WITH CHRONIC HYPERCAPNIC RESPIRATORY FAILURE IN OUTPATIENT PRACTICE

2020 ◽  
pp. 178-181
Author(s):  
Вероника Ивановна Шевцова ◽  
Анна Александровна Зуйкова ◽  
Юлия Александровна Котова ◽  
Артём Николаевич Шевцов
Keyword(s):  
Respiratory Failure ◽  
Sleep Disturbances ◽  
Depression Scale ◽  
Subsequent Development ◽  
Chronic Respiratory Failure ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Outpatient Unit ◽  
History Of ◽  
Outpatient Practice

В статье приведен анализ частоты встречаемости и характера соматической патологии у пациентов с вентиляционной хронической дыхательной недостаточностью в амбулаторно-поликлиническом звене. Обследовано 66 пациентов, разделенных на две группы, в возрасте от 45 до 82 лет. У всех пациентов учитывались имеющаяся соматическая патология, уровень общего холестерина крови, индекс массы тела, наличие нарушений сна и курения в анамнезе, уровень тревоги и депрессии «Госпитальная шкала тревоги и депрессии (HADS)». Определено, что наиболее распространенными нозологиями у пациентов с хронической дыхательной недостаточностью в данном исследовании являлись гипертоническая болезнь, что патогенетически может быть связано с наличием эндотелиальной дисфункции, и дисциркуляторная энцефалопатия. Сочетание данных нозологий с ожирением, нарушениями сна и повышенной тревожностью и/или депрессией при отсутствии активных жалоб может указывать на субклиническую хроническую дыхательную недостаточность. Курение в анамнезе может быть фактором, влияющим на развитие дыхательной недостаточности в последующем. Измерение сатурации во время поликлинического приёма целесообразно для выявления дыхательной недостаточности у пациентов на приеме, в особенности при отсутствии активных жалоб To analyze the incidence and nature of somatic pathology in patients with chronic ventilatory respiratory failure in an outpatient unit. We examined 66 patients, divided into two groups, aged 45 to 82 years. The Hospital Anxiety and Depression Scale (HADS) was used. The most common nosologies in patients with chronic respiratory failure in this study were hypertension and discirculatory encephalopathy, which pathogenetically may be associated with the presence of endothelial dysfunction. The combination of these nosologies with obesity, sleep disturbances and increased anxiety and / or depression in the absence of active complaints may indicate subclinical chronic respiratory failure. A history of smoking may be a factor in the subsequent development of respiratory failure. Measurement of saturation during outpatient use is advisable to detect respiratory failure in patients at the reception, especially in the absence of active complaints

scholarly journals Anxiety and Depression among Patients with Coronary Artery Disease Attending at a Cardiac Center, Kathmandu, Nepal

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Puja Sharma Dhital ◽  
Kalpana Sharma ◽  
Pratik Poudel ◽  
Pankaj Raj Dhital
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Family Income ◽  
Psychiatric Morbidity ◽  
Depression Scale ◽  
Self Esteem ◽  
Anxiety And Depression ◽  
Bivariate Analysis ◽  
Semistructured Interview ◽  
Artery Disease

Psychiatric morbidity such as anxiety and depression is common among patients with coronary artery disease (CAD). The coexistence of psychiatric morbidity negatively affects the outcome of treatment and increases the overall burden of disease in CAD patients. The objective of the study was to identify the level of anxiety and depression among patients with CAD. Descriptive, cross-sectional research design and purposive sampling were used and a total of 168 patients having coronary artery disease were selected purposively for the study from the patients attending cardiac outpatient department of Sahid Gangalaal National Heart Center, Kathmandu, Nepal. Data was collected on 2017 by using pretested semistructured interview schedule, Hospital Anxiety and Depression Scale. The findings showed that 27.4% of the respondents had anxiety caseness and 23.8% of the respondents had depression caseness. Bivariate analysis showed that patient’s level of anxiety was significantly associated with sex, family income, occupation status, and self-esteem. Higher level of anxiety (42.4%) was found in female than male patients. Likewise, level of depression was significantly associated with education status, occupation status, presence of comorbidities, physical exercise, and self-esteem of the patients. There was significant positive relationship between anxiety and depression score. Thus anxiety and depression were common among patients with CAD. Hence, anxiety and depression in CAD patients need be monitored regularly, provide regular counseling services, and refer the patients for the treatment when needed.

scholarly journals The Role of Sleep Disturbance, Depression and Anxiety in Frail Patients with AF–Gender Differences

2020 ◽  
Vol 10 (1) ◽  
pp. 11
Author(s):  
Beata Jankowska-Polańska ◽  
Jacek Polański ◽  
Krzysztof Dudek ◽  
Agnieszka Sławuta ◽  
Grzegorz Mazur ◽  
...  
Keyword(s):  
Gender Differences ◽  
Sleep Disturbance ◽  
Sleep Disturbances ◽  
Depressive Disorders ◽  
Reference Group ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Frail Patients ◽  
Anxiety Depression ◽  
The Impact

The aim of the study was to assess the link between anxiety and depression and frailty syndrome (FS) in patients with atrial fibrillation (AF) with regard to gender differences. Material and methods. The study was conducted on 158 patients with AF (mean age 70.4 ± 7.6). The study used the hospital anxiety and depression scale (HADS-M), the Athens insomnia scale (AIS) and the Edmonton frailty scale to assess and compare anxiety, depression, and sleep disturbance between frail and non-frail patients with AF. Results. FS was diagnosed in 53.2% of patients. A comparative analysis showed a statistically significantly higher severity level of anxiety (12.0 ± 2.6 vs. 8.4 ± 2.5, p < 0.001) and depression (12.5 ± 2.5 vs. 7.2 ± 3.3, p < 0.001) in frail patients compared to non-frail patients. The analysis of the level of anxiety, depression and FS did not show any significant differences between the studied women and men. However, statistically, significant differences were observed when FS occurred, regardless of gender. Anxiety disorders were observed in 75.5% of patients with FS and in 16.7% without frailty, whereas depressive disorders were observed in 73.6% of frail patients and in 4.2% without frailty. In an analysis of the impact of cumulative variables on the level of frailty, the risk of FS in patients with anxiety/depression and sleep disturbance is almost 500 times higher compared to patients without anxiety/depression and sleep disturbance. The risk of frailty in patients with sleep disturbance only is thirteen times higher than in the reference group, i.e., in patients without depression/anxiety and sleep disturbances. Conclusions: Patients with AF and FS show deeper anxiety, depression and sleep disturbances. Gender does not influence the risk of frailty in AF patients. Frailty in patients with AF is associated with a higher risk of depression, sleep disturbances and anxiety.

scholarly journals 726 Relationships Between Sleep and Psychological Adjustment During the COVID-19 Pandemic

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A283-A283
Author(s):  
Allyson Gilles ◽  
Fares Qeadan ◽  
Kelly Baron
Keyword(s):  
Psychological Adjustment ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Mixed Effect ◽  
Severity Scores ◽  
Significant Difference ◽  
Independent Effects ◽  
Insomnia Symptoms ◽  
Insomnia Severity ◽  
Over Time

Abstract Introduction Disruption of daily routines (employment, social interaction, health behaviors) during the COVID-19 pandemic has contributed to psychological distress (worry, rumination), likely impacting sleep-related behaviors. This study evaluated change in psychological adjustment and insomnia symptoms during the COVID-19 pandemic. Methods The sample included 192 adults from Utah who completed three data collection cycles across 9 consecutive months to assess self-reported depressive, anxiety, and insomnia symptoms. Anxiety and depressive symptoms were assessed via the Generalized Anxiety Disorder scale (GAD-7) and Patient Health Questionnaire depression scale (PHQ-8). Insomnia was measured by the Insomnia Severity Index (ISI). Data were analyzed using mixed-effect modeling and adjusted for anxiety and depression to determine their independent effects on insomnia symptoms. Spaghetti plots examined mean changes over time and significance was set at p&lt;0.05. Average anxiety, depression, and insomnia severity scores were aggregated for each month. Results As participants’ symptoms of anxiety and depression increased in severity, insomnia symptoms increased similarly. Over half of participants reported clinically significant ISI scores (59.38%). In both the random intercept and random slope models, there were significant independent effects of anxiety on insomnia severity (F=20.69; p&lt;0.0001) and significant effects of depression on insomnia severity (F=87.44, p&lt;0.0001). While the change in insomnia severity over time was on the boundary of statistical significance (F=3.54; p=0.0618), dropping from 15.17 (April) to 12.58 (December), our longitudinal analyses revealed no significant difference for the effect of anxiety or depression in predicting insomnia severity over time. Participants’ monthly averages varied for sleep and psychological scores (ISI) from 12.58 to 16.07 (SD=3.76 to 6.34 for December and September, respectively), (GAD-7) from 3.47 to 6.39 (SD=3.36 to 5.26 for December and June, respectively), and (PHQ-8) 4.47 to 6.10 (SD=4.65 to 4.39 for December and June, respectively). Conclusion Results demonstrate high prevalence of insomnia symptoms during the COVID-19 pandemic and underscore the importance of examining mental health functioning and psychological resiliency on sleep in order to enhance prevention efforts in response to a significant stressor. Support (if any):

scholarly journals A Novel Group Cognitive Behavioral Therapy Approach to Adult Non-rapid Eye Movement Parasomnias

2021 ◽  
Vol 12 ◽  
Author(s):  
David O'Regan ◽  
Alexander Nesbitt ◽  
Nazanin Biabani ◽  
Panagis Drakatos ◽  
Hugh Selsick ◽  
...  
Keyword(s):  
Eye Movement ◽  
Behavioral Therapy ◽  
Depression Scale ◽  
Severity Index ◽  
Anxiety And Depression ◽  
Severity Scale ◽  
Hospital Anxiety ◽  
Clinical Measures ◽  
Insomnia Severity

Background: Following the success of Cognitive Behavioral Therapy (CBT) for insomnia, there has been a growing recognition that similar treatment approaches might be equally beneficial for other major sleep disorders, including non-rapid eye movement (NREM) parasomnias. We have developed a novel, group-based, CBT-program for NREM parasomnias (CBT-NREMP), with the primary aim of reducing NREM parasomnia severity with relatively few treatment sessions.Methods: We investigated the effectiveness of CBT-NREMP in 46 retrospectively-identified patients, who completed five outpatient therapy sessions. The outcomes pre- and post- CBT-NREMP treatment on clinical measures of insomnia (Insomnia Severity Index), NREM parasomnias (Paris Arousal Disorders Severity Scale) and anxiety and depression (Hospital Anxiety and Depression Scale), were retrospectively collected and analyzed. In order to investigate the temporal stability of CBT-NREMP, we also assessed a subgroup of 8 patients during the 3 to 6 months follow-up period.Results: CBT-NREMP led to a reduction in clinical measures of NREM parasomnia, insomnia, and anxiety and depression severities [pre- vs. post-CBT-NREMP scores: P (Insomnia Severity Index) = 0.000054; P (Paris Arousal Disorders Severity Scale) = 0.00032; P (Hospital Anxiety and Depression Scale) = 0.037]. Improvements in clinical measures of NREM parasomnia and insomnia severities were similarly recorded for a subgroup of eight patients at follow-up, demonstrating that patients continued to improve post CBT-NREMP.Conclusion: Our findings suggest that group CBT-NREMP intervention is a safe, effective and promising treatment for NREM parasomnia, especially when precipitating and perpetuating factors are behaviorally and psychologically driven. Future randomized controlled trials are now required to robustly confirm these findings.

scholarly journals P205 Influencing factors of Sleep quality in patients with Crohn’s Disease

2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S267-S267
Author(s):  
M Sabbah ◽  
H Jlassi ◽  
N Bellil ◽  
D Trad ◽  
A Ouakaa ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Influencing Factors ◽  
Severity Score ◽  
Sleep Disturbances ◽  
Severity Index ◽  
Anxiety And Depression ◽  
Fatigue Score ◽  
Insomnia Severity Index ◽  
Fatigue Severity ◽  
Insomnia Severity

Abstract Background Sleep is considered vital for the health and quality of life of individuals. Recently, studies have suggested that sleep disturbances are common in people with Crohn’s disease (CD) and in the majority of cases are related to disease activity.The aim of our study was to determine the prevalence of insomnia in patients with CD and to identify the influencing factors. Methods A prospective cross-sectional study including patients with CD followed in the department between July and August 2020 was carried out. Epidemiological and clinical data have been collected. Self-report questionnaires were given to patients. Insomnia was assessed using the Insomnia Severity Index (ISI) which provides a valid index of the overall severity of insomnia. A score between 0 and 7 indicates the absence of insomnia; between 8 and 14 a mild infra-clinical insomnia; between 15 and 21 moderate clinical insomnia, and between 22 and 28 severe insomnia. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS) questionnaire which is a scale of 14 items rated from 0 to 3. Seven questions are related to anxiety and seven to depression. Fatigue was screened for using the Fatigue Severity Scale (FSS) which has 9 questions rated from one to seven. Significant fatigue was defined by a score greater than or equal to 5.5. Statistical analysis was performed by SPSS 21 software (p significant if less than 0.05). Results Thirty two patients with a mean age of 38.28 years [18–60 years] and a sex ratio equal to 1 were enrolled. Mean duration of the disease was 10.56 years [1–40 years]. At the time of inclusion, the average Harvey Bradshaw (HAB) score was 5.14 [1–14]. Mean insomnia score was 12.62 [0–26]. The insomnia severity index showed mild insomnia in 4 patients (12.5%), moderate insomnia in 7 patients (22%) and severe insomnia in 8 patients (25%). The HADS score revealed obvious depression in 19% of patients, doubtful depression in 25% of patients. 56% of patients had no symptoms of depression. Likewise, anxiety was objectified in 22% of patients and doubtful anxiety in 37% of patients. 41% of patients had no symptoms of anxiety. The mean fatigue score was 3.75 ± 1.9 [range 1–9]. A fatigue score greater than or equal to 5.5 was observed in 3 cases (9%). A significant positive correlation was found between the insomnia severity score and the depression score (r = 0.4, p = 0.035) as well as the fatigue severity score (r: 0.36, p = 0.04). Conclusion Our study shows that insomnia is very common in patients with CD. The factors associated with these sleep disturbances were depression and fatigue. Gastroenterologist and psychologist should join forces to evaluate emotional as well as sleep disturbances for a better global CD management.

Sign in / Sign up

Export Citation Format

Share Document